Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 22 November, 2025
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 505710 | NSE: GRAUWEIL

Grauer & Weil (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 3:03 pm

Market Cap 3,679 Cr.
Current Price 81.2
High / Low 111/78.0
Stock P/E24.4
Book Value 22.0
Dividend Yield0.62 %
ROCE23.3 %
ROE17.6 %
Face Value 1.00
PEG Ratio1.76

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Grauer & Weil (India) Ltd

Competitors of Grauer & Weil (India) Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
HP Adhesives Ltd 425 Cr. 46.1 86.7/42.626.4 20.50.87 %13.6 %9.82 % 2.00
Haryana Leather Chemicals Ltd 35.2 Cr. 71.7 103/56.016.8 89.61.40 %8.02 %5.45 % 10.0
Hardcastle & Waud Mfg Co Ltd 46.2 Cr. 680 988/60021.3 6970.00 %6.31 %2.91 % 10.0
Grauer & Weil (India) Ltd 3,679 Cr. 81.2 111/78.024.4 22.00.62 %23.3 %17.6 % 1.00
DMCC Speciality Chemicals Ltd 656 Cr. 263 453/24123.6 93.80.95 %14.1 %9.97 % 10.0
Industry Average12,884.24 Cr741.8663.68182.930.42%12.99%25.41%6.41

All Competitor Stocks of Grauer & Weil (India) Ltd

Quarterly Result

MetricJun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Sales 199205251327200250285333264255275340253
Expenses 159166204297152202230294200212222311201
Operating Profit 40394730484955396443523053
OPM % 20%19%19%9%24%20%19%12%24%17%19%9%21%
Other Income 44546798814121213
Interest 0-011000300121
Depreciation 5555555556666
Profit before tax 39384729485158396751583458
Tax % 25%26%26%25%23%26%26%26%24%26%26%25%25%
Net Profit 29283422373743295138432644
EPS in Rs 0.640.620.760.480.810.830.940.641.120.830.950.570.96

Last Updated: August 19, 2025, 2:25 pm

Below is a detailed analysis of the quarterly data for Grauer & Weil (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

  • For Sales, as of Jun 2025, the value is 253.00 Cr.. The value appears to be declining and may need further review. It has decreased from 340.00 Cr. (Mar 2025) to 253.00 Cr., marking a decrease of 87.00 Cr..
  • For Expenses, as of Jun 2025, the value is 201.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 311.00 Cr. (Mar 2025) to 201.00 Cr., marking a decrease of 110.00 Cr..
  • For Operating Profit, as of Jun 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Mar 2025) to 53.00 Cr., marking an increase of 23.00 Cr..
  • For OPM %, as of Jun 2025, the value is 21.00%. The value appears strong and on an upward trend. It has increased from 9.00% (Mar 2025) to 21.00%, marking an increase of 12.00%.
  • For Other Income, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 1.00 Cr..
  • For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
  • For Depreciation, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
  • For Profit before tax, as of Jun 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2025) to 58.00 Cr., marking an increase of 24.00 Cr..
  • For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
  • For Net Profit, as of Jun 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2025) to 44.00 Cr., marking an increase of 18.00 Cr..
  • For EPS in Rs, as of Jun 2025, the value is 0.96. The value appears strong and on an upward trend. It has increased from 0.57 (Mar 2025) to 0.96, marking an increase of 0.39.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:13 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 3804094134324976006186057689811,0681,1341,159
Expenses 319333335346400494521505655825877944982
Operating Profit 617678869810697101114156191189178
OPM % 16%19%19%20%20%18%16%17%15%16%18%17%15%
Other Income 312410520151618314648
Interest 1714103323333543
Depreciation 12161414151519182020212224
Profit before tax 3546567391949594107152196210199
Tax % 14%28%24%26%30%32%21%27%26%26%25%25%
Net Profit 303342546464766979113146157151
EPS in Rs 0.670.740.931.201.411.411.671.521.742.493.233.473.33
Dividend Payout % 12%15%15%17%21%21%15%16%19%16%8%14%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)10.00%27.27%28.57%18.52%0.00%18.75%-9.21%14.49%43.04%29.20%7.53%
Change in YoY Net Profit Growth (%)0.00%17.27%1.30%-10.05%-18.52%18.75%-27.96%23.70%28.55%-13.83%-21.67%

Grauer & Weil (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:11%
5 Years:13%
3 Years:14%
TTM:-1%
Compounded Profit Growth
10 Years:16%
5 Years:17%
3 Years:26%
TTM:-6%
Stock Price CAGR
10 Years:28%
5 Years:35%
3 Years:40%
1 Year:-11%
Return on Equity
10 Years:17%
5 Years:17%
3 Years:18%
Last Year:18%

Last Updated: September 5, 2025, 3:40 pm

No data available for the Balance Sheet data table.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +4955778771338411744114160144
Cash from Investing Activity +-6-9-8-54-61-13-53-43-17-116-109-120
Cash from Financing Activity +-43-46-62-10-25-2-36-3-15-19-20-42
Net Cash Flow00823-1417-57112-2131-19

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days898070636568677762686364
Inventory Days109120115118100106126108121839098
Days Payable7967688281689511091778690
Cash Conversion Cycle1191331179983106997592756872
Working Capital Days172650384956573649433432
ROCE %18%21%24%25%27%26%20%19%19%24%26%23%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters69.04%69.04%69.04%69.04%69.04%69.04%69.04%69.04%69.04%69.03%69.03%69.03%
FIIs1.24%1.40%1.21%1.21%1.07%0.95%0.91%0.95%0.85%0.86%0.79%0.68%
DIIs0.11%0.19%0.02%0.02%0.02%0.02%0.02%0.05%0.09%0.10%0.02%0.03%
Public29.59%29.36%29.73%29.73%29.87%29.99%30.03%29.98%30.03%30.01%30.15%30.26%
No. of Shareholders42,21841,14644,03043,85243,66049,45058,40260,54061,71459,92557,37155,578

Shareholding Pattern Chart

No. of Shareholders

Grauer & Weil (India) Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE / ROE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 3.476.454.983.473.04
Diluted EPS (Rs.) 3.476.454.983.473.04
Cash EPS (Rs.) 3.967.385.864.343.85
Book Value[Excl.RevalReserv]/Share (Rs.) 20.7235.5229.9625.6922.67
Book Value[Incl.RevalReserv]/Share (Rs.) 20.7235.5229.9625.6922.67
Revenue From Operations / Share (Rs.) 25.0047.1543.3133.8926.72
PBDIT / Share (Rs.) 5.189.777.695.585.07
PBIT / Share (Rs.) 4.688.846.824.714.26
PBT / Share (Rs.) 4.628.666.704.714.16
Net Profit / Share (Rs.) 3.476.454.983.473.04
NP After MI And SOA / Share (Rs.) 3.476.454.983.473.04
PBDIT Margin (%) 20.7020.7117.7516.4518.97
PBIT Margin (%) 18.7318.7415.7413.9015.93
PBT Margin (%) 18.4818.3515.4713.8915.57
Net Profit Margin (%) 13.8613.6811.5010.2411.37
NP After MI And SOA Margin (%) 13.8613.6811.5010.2511.35
Return on Networth / Equity (%) 16.7318.1616.6213.5213.38
Return on Capital Employeed (%) 21.4723.2421.1116.8816.97
Return On Assets (%) 12.2212.9911.839.559.17
Total Debt / Equity (X) 0.010.020.020.030.03
Asset Turnover Ratio (%) 0.941.031.100.970.86
Current Ratio (X) 3.153.162.872.892.75
Quick Ratio (X) 2.632.642.302.142.24
Inventory Turnover Ratio (X) 7.714.224.113.813.03
Dividend Payout Ratio (NP) (%) 14.4222.4713.0414.380.00
Dividend Payout Ratio (CP) (%) 12.6219.6311.0911.510.00
Earning Retention Ratio (%) 85.5877.5386.9685.620.00
Cash Earning Retention Ratio (%) 87.3880.3788.9188.490.00
Interest Coverage Ratio (X) 85.6753.7793.6350.3653.33
Interest Coverage Ratio (Post Tax) (X) 58.3736.5162.0431.3732.99
Enterprise Value (Cr.) 3259.263602.561964.441088.88653.83
EV / Net Operating Revenue (X) 2.873.372.001.421.08
EV / EBITDA (X) 13.8816.2711.278.615.69
MarketCap / Net Operating Revenue (X) 3.283.742.271.731.47
Retention Ratios (%) 85.5777.5286.9585.610.00
Price / BV (X) 3.964.973.292.281.73
Price / Net Operating Revenue (X) 3.283.742.271.731.47
EarningsYield 0.040.030.050.050.07

After reviewing the key financial ratios for Grauer & Weil (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 3.47. This value is below the healthy minimum of 5. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 3.47. This value is below the healthy minimum of 5. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
  • For Cash EPS (Rs.), as of Mar 25, the value is 3.96. This value is within the healthy range. It has decreased from 7.38 (Mar 24) to 3.96, marking a decrease of 3.42.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 20.72. It has decreased from 35.52 (Mar 24) to 20.72, marking a decrease of 14.80.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 20.72. It has decreased from 35.52 (Mar 24) to 20.72, marking a decrease of 14.80.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 25.00. It has decreased from 47.15 (Mar 24) to 25.00, marking a decrease of 22.15.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 5.18. This value is within the healthy range. It has decreased from 9.77 (Mar 24) to 5.18, marking a decrease of 4.59.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 4.68. This value is within the healthy range. It has decreased from 8.84 (Mar 24) to 4.68, marking a decrease of 4.16.
  • For PBT / Share (Rs.), as of Mar 25, the value is 4.62. This value is within the healthy range. It has decreased from 8.66 (Mar 24) to 4.62, marking a decrease of 4.04.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 3.47. This value is within the healthy range. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.47. This value is within the healthy range. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
  • For PBDIT Margin (%), as of Mar 25, the value is 20.70. This value is within the healthy range. It has decreased from 20.71 (Mar 24) to 20.70, marking a decrease of 0.01.
  • For PBIT Margin (%), as of Mar 25, the value is 18.73. This value is within the healthy range. It has decreased from 18.74 (Mar 24) to 18.73, marking a decrease of 0.01.
  • For PBT Margin (%), as of Mar 25, the value is 18.48. This value is within the healthy range. It has increased from 18.35 (Mar 24) to 18.48, marking an increase of 0.13.
  • For Net Profit Margin (%), as of Mar 25, the value is 13.86. This value exceeds the healthy maximum of 10. It has increased from 13.68 (Mar 24) to 13.86, marking an increase of 0.18.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.86. This value is within the healthy range. It has increased from 13.68 (Mar 24) to 13.86, marking an increase of 0.18.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 16.73. This value is within the healthy range. It has decreased from 18.16 (Mar 24) to 16.73, marking a decrease of 1.43.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 21.47. This value is within the healthy range. It has decreased from 23.24 (Mar 24) to 21.47, marking a decrease of 1.77.
  • For Return On Assets (%), as of Mar 25, the value is 12.22. This value is within the healthy range. It has decreased from 12.99 (Mar 24) to 12.22, marking a decrease of 0.77.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 0.94. It has decreased from 1.03 (Mar 24) to 0.94, marking a decrease of 0.09.
  • For Current Ratio (X), as of Mar 25, the value is 3.15. This value exceeds the healthy maximum of 3. It has decreased from 3.16 (Mar 24) to 3.15, marking a decrease of 0.01.
  • For Quick Ratio (X), as of Mar 25, the value is 2.63. This value exceeds the healthy maximum of 2. It has decreased from 2.64 (Mar 24) to 2.63, marking a decrease of 0.01.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has increased from 4.22 (Mar 24) to 7.71, marking an increase of 3.49.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.42. This value is below the healthy minimum of 20. It has decreased from 22.47 (Mar 24) to 14.42, marking a decrease of 8.05.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 12.62. This value is below the healthy minimum of 20. It has decreased from 19.63 (Mar 24) to 12.62, marking a decrease of 7.01.
  • For Earning Retention Ratio (%), as of Mar 25, the value is 85.58. This value exceeds the healthy maximum of 70. It has increased from 77.53 (Mar 24) to 85.58, marking an increase of 8.05.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.38. This value exceeds the healthy maximum of 70. It has increased from 80.37 (Mar 24) to 87.38, marking an increase of 7.01.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 85.67. This value is within the healthy range. It has increased from 53.77 (Mar 24) to 85.67, marking an increase of 31.90.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 58.37. This value is within the healthy range. It has increased from 36.51 (Mar 24) to 58.37, marking an increase of 21.86.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 3,259.26. It has decreased from 3,602.56 (Mar 24) to 3,259.26, marking a decrease of 343.30.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.87. This value is within the healthy range. It has decreased from 3.37 (Mar 24) to 2.87, marking a decrease of 0.50.
  • For EV / EBITDA (X), as of Mar 25, the value is 13.88. This value is within the healthy range. It has decreased from 16.27 (Mar 24) to 13.88, marking a decrease of 2.39.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.28. This value exceeds the healthy maximum of 3. It has decreased from 3.74 (Mar 24) to 3.28, marking a decrease of 0.46.
  • For Retention Ratios (%), as of Mar 25, the value is 85.57. This value exceeds the healthy maximum of 70. It has increased from 77.52 (Mar 24) to 85.57, marking an increase of 8.05.
  • For Price / BV (X), as of Mar 25, the value is 3.96. This value exceeds the healthy maximum of 3. It has decreased from 4.97 (Mar 24) to 3.96, marking a decrease of 1.01.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.28. This value exceeds the healthy maximum of 3. It has decreased from 3.74 (Mar 24) to 3.28, marking a decrease of 0.46.
  • For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Grauer & Weil (India) Ltd as of November 24, 2025 is: 76.05

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 24, 2025, Grauer & Weil (India) Ltd is Overvalued by 6.34% compared to the current share price 81.20

Intrinsic Value of Grauer & Weil (India) Ltd as of November 24, 2025 is: 86.59

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 24, 2025, Grauer & Weil (India) Ltd is Undervalued by 6.64% compared to the current share price 81.20

Last 5 Year EPS CAGR: 13.86%

*Investments are subject to market risks

Strength and Weakness

Unable to fetch valid data for stock valuation.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Grauer & Weil (India) Ltd:
    1. Net Profit Margin: 13.86%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 21.47% (Industry Average ROCE: 12.99%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 16.73% (Industry Average ROE: 25.41%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 58.37
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 2.63
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 24.4 (Industry average Stock P/E: 63.68)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.01
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Grauer & Weil (India) Ltd. is a Public Limited Listed company incorporated on 25/11/1957 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L74999MH1957PLC010975 and registration number is 010975. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 1127.56 Cr. and Equity Capital is Rs. 45.34 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Chemicals - Speciality - OthersGrowel Corporate, Mumbai Maharashtra 400101secretarial@growel.com
http://www.growel.com
Management
NamePosition Held
Mr. Umeshkumar MoreChairman
Mr. Nirajkumar MoreManaging Director
Mr. Rohitkumar MoreWhole Time Director
Mr. Yogesh SamatWhole Time Director
Dr. Prerna GoradiaIndependent Director
Mr. Ayush AgarwalaIndependent Director
Mr. Ashok Kumar KanodiaIndependent Director
Mr. Anil GadodiaIndependent Director
FAQ: Stock data is invalid or not in the correct format.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Grauer & Weil (India) Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore More Stocks